OrthoDirectUSA helps healthcare providers transition to value-based purchasing models through their Operating Room Device Technician (ORDT) Program. This program trains providers' staff to replace commercial sales representatives in the operating room and manage implant purchasing. It allows providers to purchase stable, FDA-approved implants directly from manufacturers at wholesale prices 50% lower. OrthoDirectUSA implements the ORDT Program and provides on-site mentoring, with fees covered by the savings from wholesale implant purchasing. The program aims to give providers more choice, control, and profit in their implant services and costs.

1. ORTHODirect
USA
OrthoDirectUSA is a company whose mission is to partner with Providers who are trying to
navigate the dramatic impact of Value-Based Purchasing (VBP).
VBP is the payment methodology that rewards quality care through payment incentives and
transparency.
Newly implemented Value Based Payment reform is expected to reduce Medicare spending by
approximately $214 billion over the next 10 years. In VBP Providers are held accountable for the
quality and cost of health care services they provide. Critical to VBP is standardized, comparative,
and transparent information on patient outcomes; healthcare status; patient experience
(satisfaction); and costs (direct, indirect) of services provide.
Value-Based Purchasing keeps value for the patient the focus. Competition, choice, and price
transparency are the central tenants of VBP. OrthoDirectUSA believes value is a function of
quality, efficiency, safety, and cost.
OrthoDirectUSA helps Providers take back control of their orthopedic implant service through
Process Change.
OrthoDirectUSA believes that the most strategic decision a Provider can make to lower their
orthopedic implant costs is to take the commercial sales representative out of the operating room.
By being willing to “Take Back Control” of managing their implant services, the Provider can
significantly impact the entire orthopedic supply chain and dramatically improve their service line
profitability. OrthoDirectUSA has developed a solution for managing this transition, The Operating
Room Device Technician (ORDT) Program, which is a Learning and Development / Change
Management Curriculum, to empower the transition to a Value-Based Purchasing, i.e., Value-
Based Care, business model.
OrthoDirectUSA enables the replacement of the commercial sales representative by training the
Provider’s most important asset, their people, in the ORDT process. OrthoDirectUSA mentors will
be onsite 24/7 to compliment the ORDT Curriculum, by teaching, training, and coaching the
enrolled hospital surgical technicians and supporting departmental personnel.

2. The outcome of engaging OrthoDirectUSA and adopting the ORDT process is that the Provider will
improve their employee talent pool and be able to manage their implant services without depending
on sales representatives. Subsequently, enabling Providers to implement a direct access-purchasing
model for stable technology devices.
Stable technologies are high quality, and most importantly, time tested product designs that have a
record of proven success. Stable Technologies have been 510k cleared by the FDA and are
substantially equivalent to the products currently being used by the provider, but can now be
purchased directly from a growing pool of manufactures who support our Value-Based business
model.
A byproduct of engaging OrthoDirectUSA, Providers will have the ability to purchase these Stable
Technologies at “wholesale” prices.
OrthoDirectUSA has identified a growing number of US manufacturers who are willing to sell FDA
cleared implants and instruments at wholesale prices because they can eliminate their traditional
selling and marketing costs. These reductions in price can amount to 50% and more.
OrthoDirectUSA generates fees for service for implementing our ORDT Program, which includes
our Learning and Development / Change Management Curriculum and On-site Mentoring. The
length of the agreement term is dependent upon the strategy and objectives of the Provider, as well
as the complexity of the implementation. Essentially, it is a self-funding business model; the net
savings impact of “wholesale” purchasing is more than sufficient to cover program expenses.
Acute care facilities engagements range from 12-24 month terms, while smaller free standing
Hospitals or Ambulatory Surgery Centers will participate in a modified version of our process for a
shorter period.
OrthoDirectUSA receive no compensation from the sale of implants and
instruments. OrthoDirectUSA works for the Provider. It is our goal to give the Provider, “More
Choice, More Control, and More Profit.”
! ! !
!
ORTHODirect
!
!
!
!
USA !
!
www.orthodirectusa.com!
888.600.4611!
!